Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (315)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2024
201
6.270
 Why?
Breast Neoplasms
26
2026
2246
4.390
 Why?
Antineoplastic Agents
23
2023
2162
2.430
 Why?
Immunoconjugates
7
2023
127
2.420
 Why?
Antineoplastic Combined Chemotherapy Protocols
20
2025
1791
2.340
 Why?
Pyrimidines
9
2021
510
2.240
 Why?
Protein Kinase Inhibitors
11
2025
918
1.780
 Why?
Piperazines
5
2023
375
1.610
 Why?
Paclitaxel
6
2022
236
1.520
 Why?
Camptothecin
9
2023
123
1.500
 Why?
Neoplasms
14
2022
2731
1.440
 Why?
Pyrazoles
6
2021
482
1.290
 Why?
Ovarian Neoplasms
5
2025
581
1.250
 Why?
Quinoxalines
2
2020
67
1.240
 Why?
Azepines
3
2020
99
1.180
 Why?
Antibodies, Monoclonal, Humanized
10
2024
908
1.160
 Why?
Histone Deacetylase Inhibitors
4
2024
211
1.140
 Why?
Cyclin-Dependent Kinase 4
2
2018
48
1.040
 Why?
Cyclin-Dependent Kinase 6
2
2018
42
1.040
 Why?
Carcinoma, Lobular
3
2026
54
0.870
 Why?
Neutropenia
4
2022
151
0.840
 Why?
Benzoxazoles
2
2021
20
0.820
 Why?
Xenograft Model Antitumor Assays
12
2026
917
0.750
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1439
0.730
 Why?
Breast Neoplasms, Male
2
2018
29
0.700
 Why?
beta Catenin
2
2020
256
0.700
 Why?
Female
54
2026
75814
0.660
 Why?
Chemotherapy, Adjuvant
4
2023
383
0.650
 Why?
Receptors, Estrogen
3
2021
412
0.650
 Why?
Maximum Tolerated Dose
9
2022
204
0.650
 Why?
Cancer Care Facilities
1
2020
43
0.650
 Why?
eIF-2 Kinase
1
2019
31
0.620
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
211
0.610
 Why?
Pyridines
5
2025
560
0.580
 Why?
Anthracyclines
3
2023
41
0.580
 Why?
Tumor Microenvironment
4
2024
711
0.580
 Why?
Humans
67
2026
141284
0.580
 Why?
Taxoids
3
2023
105
0.570
 Why?
Aged
26
2025
24836
0.540
 Why?
Carcinoma, Ductal, Breast
1
2018
81
0.540
 Why?
Aurora Kinase A
4
2020
56
0.540
 Why?
Wnt Signaling Pathway
1
2019
202
0.530
 Why?
Trastuzumab
4
2023
98
0.530
 Why?
Drug Resistance, Neoplasm
4
2020
840
0.530
 Why?
Aromatase Inhibitors
3
2025
58
0.510
 Why?
Pyrazines
2
2018
88
0.510
 Why?
Colonic Neoplasms
1
2018
244
0.490
 Why?
Myocardial Infarction
1
2023
1066
0.490
 Why?
Tumor Suppressor Protein p53
4
2024
528
0.470
 Why?
Angiopoietin-1
1
2015
11
0.460
 Why?
Angiopoietin-2
1
2015
15
0.460
 Why?
Neoplasm Recurrence, Local
5
2025
1075
0.460
 Why?
Nuclear Proteins
2
2023
718
0.460
 Why?
Neoadjuvant Therapy
1
2018
429
0.460
 Why?
Cell Line, Tumor
10
2026
3502
0.440
 Why?
Medicare
4
2023
802
0.420
 Why?
Middle Aged
27
2025
34658
0.410
 Why?
Uterine Cervical Neoplasms
1
2017
268
0.410
 Why?
Bridged-Ring Compounds
2
2023
27
0.400
 Why?
Colorectal Neoplasms
5
2022
811
0.390
 Why?
Adult
28
2025
39319
0.390
 Why?
Dose-Response Relationship, Drug
6
2022
2047
0.380
 Why?
Quinolines
4
2025
169
0.380
 Why?
Tumor Suppressor Proteins
1
2015
325
0.380
 Why?
Proto-Oncogene Proteins c-met
1
2013
71
0.380
 Why?
Antibodies, Monoclonal
4
2024
1456
0.380
 Why?
Cell Proliferation
8
2020
2502
0.380
 Why?
Treatment Outcome
13
2025
11216
0.370
 Why?
Recombinant Fusion Proteins
1
2015
672
0.370
 Why?
Antineoplastic Agents, Immunological
3
2019
191
0.370
 Why?
Radiosurgery
3
2025
389
0.370
 Why?
Point Mutation
1
2013
239
0.370
 Why?
Triazoles
1
2013
163
0.360
 Why?
Angiogenesis Inhibitors
3
2018
229
0.350
 Why?
Mice, Nude
6
2020
700
0.340
 Why?
Aged, 80 and over
10
2025
7948
0.330
 Why?
Clinical Trials, Phase I as Topic
2
2020
51
0.330
 Why?
Carcinoma, Renal Cell
1
2013
221
0.330
 Why?
Heart Failure
1
2023
2096
0.330
 Why?
Mitochondria
1
2017
962
0.330
 Why?
Histones
3
2023
641
0.320
 Why?
Genes, BRCA2
1
2009
30
0.310
 Why?
Neoplasm Metastasis
4
2020
674
0.310
 Why?
Genes, BRCA1
1
2009
41
0.310
 Why?
Adaptor Proteins, Signal Transducing
2
2026
436
0.310
 Why?
Biomarkers, Tumor
2
2014
1250
0.300
 Why?
Molecular Targeted Therapy
3
2019
420
0.300
 Why?
BRCA2 Protein
1
2009
62
0.300
 Why?
Pregnancy Complications, Neoplastic
1
2009
57
0.300
 Why?
Apoptosis
7
2024
2487
0.290
 Why?
Thrombophilia
1
2009
90
0.290
 Why?
Neoplasm Staging
5
2021
1397
0.290
 Why?
Kidney Neoplasms
1
2013
400
0.290
 Why?
Lung Neoplasms
2
2024
2554
0.290
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
134
0.280
 Why?
Adenine
2
2021
335
0.280
 Why?
Receptors, Progesterone
2
2021
337
0.270
 Why?
DNA-Binding Proteins
1
2015
1483
0.270
 Why?
Mice
10
2026
17969
0.260
 Why?
Models, Biological
1
2014
1810
0.240
 Why?
Cell Cycle Proteins
3
2026
628
0.240
 Why?
Selective Estrogen Receptor Modulators
1
2025
32
0.230
 Why?
Doxorubicin
3
2024
369
0.230
 Why?
Cardiorespiratory Fitness
1
2025
69
0.220
 Why?
Cyclophosphamide
2
2018
257
0.210
 Why?
DNA Repair
1
2026
240
0.210
 Why?
Trans-Activators
1
2026
395
0.200
 Why?
Animals
12
2026
37328
0.200
 Why?
Disease Models, Animal
3
2021
4414
0.200
 Why?
Brain Neoplasms
3
2025
1282
0.190
 Why?
United States
5
2023
15298
0.190
 Why?
Liver Neoplasms
1
2009
741
0.190
 Why?
Biopsy
2
2018
1073
0.190
 Why?
Cyclin-Dependent Kinase 9
1
2022
18
0.190
 Why?
Histone Deacetylase 1
1
2022
21
0.190
 Why?
Aurora Kinases
2
2012
28
0.180
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
45
0.180
 Why?
Topoisomerase I Inhibitors
2
2022
16
0.180
 Why?
Administration, Oral
3
2022
825
0.180
 Why?
Fluorouracil
1
2022
207
0.180
 Why?
Disease Progression
4
2019
2808
0.180
 Why?
Acetylation
1
2022
245
0.170
 Why?
Androstadienes
1
2021
74
0.170
 Why?
Biliary Tract Neoplasms
1
2021
30
0.170
 Why?
Arrhythmias, Cardiac
1
2023
345
0.170
 Why?
Diarrhea
2
2019
183
0.170
 Why?
Carboplatin
1
2021
145
0.170
 Why?
Heterografts
1
2021
135
0.170
 Why?
Drug Administration Schedule
3
2017
771
0.170
 Why?
Cancer Survivors
1
2025
281
0.170
 Why?
Hospitals, University
1
2021
176
0.160
 Why?
Necrosis
2
2019
245
0.160
 Why?
Histone Deacetylases
1
2022
207
0.160
 Why?
Fatigue
2
2022
342
0.160
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.160
 Why?
Immunotherapy
2
2023
641
0.160
 Why?
Clinical Trials as Topic
3
2016
1035
0.160
 Why?
Immune System
1
2021
183
0.150
 Why?
Benzodiazepines
1
2021
162
0.150
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
40
0.150
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
131
0.150
 Why?
Male
14
2021
70140
0.150
 Why?
Kaplan-Meier Estimate
1
2021
910
0.150
 Why?
Tumor Cells, Cultured
1
2020
959
0.150
 Why?
Albumins
1
2019
111
0.140
 Why?
Aquaporin 4
1
2019
100
0.140
 Why?
Maintenance Chemotherapy
1
2018
38
0.140
 Why?
Vascular Endothelial Growth Factor A
2
2018
547
0.140
 Why?
Nausea
1
2018
111
0.140
 Why?
Aminopyridines
1
2018
107
0.140
 Why?
Mice, Inbred BALB C
1
2020
1261
0.140
 Why?
Antibodies, Bispecific
1
2018
59
0.130
 Why?
Drug Therapy, Combination
1
2020
1043
0.130
 Why?
Breast
1
2018
155
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
217
0.130
 Why?
Purines
1
2018
182
0.130
 Why?
Topotecan
1
2017
13
0.130
 Why?
Mastectomy
1
2018
152
0.130
 Why?
Isoflavones
1
2017
26
0.130
 Why?
Benzimidazoles
1
2018
191
0.130
 Why?
Calcium-Binding Proteins
1
2018
213
0.130
 Why?
Imidazoles
1
2018
251
0.130
 Why?
Survival Analysis
1
2020
1322
0.130
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
19
0.130
 Why?
Carbolines
1
2017
35
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
258
0.130
 Why?
Inhibitory Concentration 50
2
2016
91
0.130
 Why?
Hypertension
2
2018
1250
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
98
0.120
 Why?
Cell Survival
1
2019
1123
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
314
0.120
 Why?
Retrospective Studies
4
2025
16447
0.120
 Why?
GPI-Linked Proteins
1
2016
78
0.120
 Why?
Neoplasms, Second Primary
1
2016
98
0.120
 Why?
Antibodies, Neoplasm
1
2015
33
0.110
 Why?
Tumor Protein p73
1
2015
18
0.110
 Why?
Nanoparticles
1
2021
481
0.110
 Why?
Phosphorylation
1
2019
1753
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
1125
0.110
 Why?
Risk Reduction Behavior
1
2016
227
0.110
 Why?
Hodgkin Disease
1
2016
158
0.110
 Why?
Oxazoles
2
2025
46
0.110
 Why?
Maytansine
1
2014
18
0.110
 Why?
Demography
1
2015
296
0.110
 Why?
Brain Edema
1
2014
63
0.110
 Why?
Protein Kinases
1
2015
307
0.100
 Why?
Drug Interactions
1
2015
404
0.100
 Why?
Exercise
1
2025
2113
0.100
 Why?
Survival Rate
2
2019
1979
0.100
 Why?
Threonine
1
2013
47
0.100
 Why?
Sulfones
1
2014
127
0.100
 Why?
Randomized Controlled Trials as Topic
1
2019
1610
0.100
 Why?
Tumor Stem Cell Assay
1
2012
34
0.100
 Why?
Quinazolines
2
2025
260
0.100
 Why?
Drug Evaluation, Preclinical
1
2013
191
0.100
 Why?
Diabetes Mellitus, Type 2
2
2025
2529
0.100
 Why?
Glycine
1
2014
187
0.100
 Why?
Drug Design
1
2013
169
0.090
 Why?
Time Factors
2
2020
6951
0.090
 Why?
Methionine
1
2013
158
0.090
 Why?
Heterozygote
1
2013
306
0.090
 Why?
Disease-Free Survival
1
2014
713
0.090
 Why?
In Situ Hybridization, Fluorescence
1
2013
310
0.090
 Why?
Analgesics, Opioid
1
2021
1117
0.090
 Why?
Treatment Failure
1
2013
355
0.090
 Why?
Neovascularization, Pathologic
1
2013
295
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
334
0.090
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
226
0.090
 Why?
Cluster Analysis
1
2012
518
0.090
 Why?
Carcinoma in Situ
1
2011
44
0.090
 Why?
Risk Assessment
1
2020
3522
0.080
 Why?
Computational Biology
1
2015
663
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
83
0.080
 Why?
Risk Factors
2
2025
10490
0.080
 Why?
Cellular Senescence
1
2012
218
0.080
 Why?
Colorado
1
2020
4599
0.080
 Why?
Sequence Analysis, DNA
1
2013
815
0.080
 Why?
Mutation
2
2012
4006
0.080
 Why?
Tumor Burden
1
2010
314
0.080
 Why?
Keratinocytes
1
2010
251
0.080
 Why?
Pregnancy Trimester, Second
1
2009
80
0.080
 Why?
Mastectomy, Segmental
1
2009
101
0.070
 Why?
Pregnancy Trimester, First
1
2009
136
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
188
0.070
 Why?
Lymph Node Excision
1
2009
169
0.070
 Why?
Risk
1
2009
903
0.060
 Why?
Cell Adhesion Molecules
2
2019
179
0.060
 Why?
Infusions, Intravenous
2
2019
418
0.060
 Why?
Prognosis
2
2018
4080
0.060
 Why?
Gene Expression Profiling
1
2012
1761
0.060
 Why?
Phthalazines
1
2026
63
0.060
 Why?
Antigens, Neoplasm
2
2019
320
0.060
 Why?
CD8-Positive T-Lymphocytes
2
2023
911
0.060
 Why?
Accelerometry
1
2025
108
0.050
 Why?
Cell Cycle
2
2018
601
0.050
 Why?
Combined Modality Therapy
2
2019
1243
0.050
 Why?
Mesylates
1
2022
6
0.050
 Why?
Follow-Up Studies
2
2025
5222
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
71
0.050
 Why?
Signal Transduction
2
2014
5116
0.050
 Why?
Oxygen Consumption
1
2025
712
0.050
 Why?
Clinical Protocols
1
2023
273
0.050
 Why?
Ligands
1
2024
665
0.040
 Why?
RNA, Small Interfering
1
2024
627
0.040
 Why?
Chimerism
1
2021
33
0.040
 Why?
Lymphocyte Subsets
1
2021
87
0.040
 Why?
Liver
1
2009
1821
0.040
 Why?
Lymphoid Tissue
1
2021
80
0.040
 Why?
Mice, SCID
1
2021
367
0.040
 Why?
Hormones
1
2020
138
0.040
 Why?
SEER Program
1
2021
219
0.040
 Why?
Mice, Inbred NOD
1
2021
599
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
24
0.040
 Why?
Tissue Distribution
1
2018
325
0.030
 Why?
Infant, Newborn
1
2009
6270
0.030
 Why?
Anemia
1
2019
175
0.030
 Why?
Insulin Resistance
1
2025
1221
0.030
 Why?
Blood Glucose
2
2025
2286
0.030
 Why?
Pregnancy
1
2009
7035
0.030
 Why?
Cetuximab
1
2016
106
0.030
 Why?
Retreatment
1
2016
74
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
123
0.030
 Why?
Neoplasm Transplantation
1
2016
251
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
195
0.030
 Why?
Carotid Artery Diseases
1
1996
62
0.030
 Why?
Platinum
1
2016
51
0.030
 Why?
Arterial Occlusive Diseases
1
1996
89
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
249
0.030
 Why?
History, Ancient
1
2015
53
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
670
0.030
 Why?
Transcription Factors
1
2023
1706
0.030
 Why?
C-Peptide
1
1996
168
0.030
 Why?
Carotid Arteries
1
1996
202
0.030
 Why?
Femoral Artery
1
1996
187
0.030
 Why?
Databases, Genetic
1
2015
244
0.030
 Why?
Diabetic Angiopathies
1
1996
250
0.030
 Why?
Biomarkers
2
2016
4180
0.030
 Why?
DNA Damage
1
2017
430
0.030
 Why?
Cross-Sectional Studies
1
2025
5653
0.030
 Why?
Mice, Knockout
1
2021
3042
0.030
 Why?
Quality of Life
1
2025
3024
0.020
 Why?
Opioid-Related Disorders
1
2021
568
0.020
 Why?
Phenotype
1
2021
3172
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
254
0.020
 Why?
Drug Combinations
1
2013
365
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
465
0.020
 Why?
Immunohistochemistry
1
2016
1724
0.020
 Why?
Lipids
1
1996
686
0.020
 Why?
Biopsy, Needle
1
2011
189
0.020
 Why?
Proto-Oncogene Proteins
1
2014
621
0.020
 Why?
HT29 Cells
1
2010
41
0.020
 Why?
Cohort Studies
1
2021
5809
0.020
 Why?
Enzyme Inhibitors
1
2014
835
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
428
0.020
 Why?
Transcription, Genetic
1
2017
1486
0.020
 Why?
ErbB Receptors
1
2013
612
0.020
 Why?
Ki-67 Antigen
1
2010
111
0.020
 Why?
Capillary Permeability
1
2010
133
0.020
 Why?
Patient Selection
1
2013
685
0.020
 Why?
Patient Satisfaction
1
2013
695
0.020
 Why?
Membrane Proteins
1
2015
1144
0.020
 Why?
Positron-Emission Tomography
1
2010
309
0.020
 Why?
Algorithms
1
2015
1764
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3734
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2765
0.010
 Why?
Insulin
1
1996
2472
0.010
 Why?
Adolescent
1
2024
22116
0.010
 Why?
Brain
1
2014
2857
0.010
 Why?
Young Adult
1
2014
13727
0.010
 Why?
Tunica Media
1
1996
36
0.010
 Why?
Cholesterol, HDL
1
1996
196
0.010
 Why?
Fasting
1
1996
283
0.010
 Why?
Cholesterol
1
1996
404
0.010
 Why?
Regression Analysis
1
1996
1013
0.010
 Why?
Ultrasonography
1
1996
765
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (315) concept(s)
_
Co-Authors Expand Description
See all (72) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)